Different individual immune responses elicited by in vitro immunization

Area of Science:

• Immunology
• Cell Biology

Background:

• Previous studies showed muramyl dipeptide (MDP), interleukin-2 (IL-2), and IL-4 enhance antibody production from L-Leucyl-L-leucine methyl ester (LLME)-treated human peripheral blood lymphocytes (PBLs) in vitro.
• Optimal cytokine concentrations for IL-2 and IL-4 vary significantly between individual donors, necessitating personalized optimization for effective in vitro immunization.

Purpose of the Study:

• To investigate individual differences in IL-2 and IL-4 requirements for in vitro antibody production using PBLs from healthy donors and patients with allergies.
• To characterize distinct immune responses in atopic individuals compared to healthy controls.

Main Methods:

• Collected PBLs from 12 volunteers (9 healthy, 3 allergic patients).
• Assessed antibody production in vitro with varying concentrations of IL-2 and IL-4.
• Analyzed differences in IgM, IgG, and IgE production between healthy and allergic donor PBLs.

Main Results:

• IL-2 requirements for antibody production were donor-dependent.
• High IL-4 concentrations inhibited IgM and IgG production in healthy donors.
• Allergic patients' PBLs exhibited lower IgM and significantly higher IgE production, even without cytokines or allergens.

Conclusions:

• PBL sensitivity to antigen sensitization differs between healthy and atopic individuals.
• These differences may reflect varying lymphocyte activation states or subpopulations in vivo.
• Personalized cytokine strategies are crucial for optimizing in vitro antibody production.